Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong · Delayed Price · Currency is HKD 8.20
-0.04 (-0.49%)
At close: Mar 6, 2026
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.98 billion as of March 6, 2026. Its market cap has increased by 31.22% in one year.
Market Cap
1.98B
Enterprise Value
1.54B
Revenue
1.43B
Ranking
n/a
PE Ratio
13.76
Stock Price
8.20
Market Cap Chart
Since November 28, 2024, HKG:2566's market cap has increased from 1.88B to 1.98B, an increase of 5.49%. That is a compound annual growth rate of 4.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.98B | 6.75% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 2.70B |
| Jiangsu Recbio Technology | 2.65B |
| Clover Biopharmaceuticals | 2.31B |
| Frontage Holdings | 2.19B |
| Antengene Corporation | 2.15B |
| Zhaoke Ophthalmology | 1.74B |
| Cutia Therapeutics | 1.68B |
| Mabpharm | 1.65B |